| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A A Shutov, A I Dondov. [Involvement of serotonergic system in the pathogenesis of non-motor symptoms of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 108. issue 11. 2009-02-23. PMID:19008805. |
the platelet serotonin level in the peripheral blood was inversely correlated with clinical form of disease, cognitive deficits and the level of anxiety and depression. |
2009-02-23 |
2023-08-12 |
Not clear |
| Gustavo Resler, Renée Lavie, Julio Campos, Salvador Mata, Mary Urbina, Alberto García, Rafael Apitz, Lucimey Lim. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes. Neuroimmunomodulation. vol 15. issue 3. 2009-02-20. PMID:18716414. |
effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin b12, and serotonin levels in lymphocytes. |
2009-02-20 |
2023-08-12 |
Not clear |
| Judit Lazary, Aron Lazary, Xenia Gonda, Anita Benko, Eszter Molnar, Gabriella Juhasz, Gyorgy Bagd. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biological psychiatry. vol 64. issue 6. 2009-02-17. PMID:18486105. |
to clarify this question, we analyzed the interaction between the serotonin transporter gene (slc6a4) and threatening life events (tle) on zung self-rating depression score (zsds). |
2009-02-17 |
2023-08-12 |
Not clear |
| Sally I Sharp, Clive G Ballard, Iryna Ziabreva, Margaret A Piggott, Robert H Perry, Elaine K Perry, Dag Aarsland, Uwe Ehrt, Jan P Larsen, Paul T Franci. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders. vol 26. issue 4. 2009-02-09. PMID:18841018. |
cortical serotonin 1a receptor levels are associated with depression in patients with dementia with lewy bodies and parkinson's disease dementia. |
2009-02-09 |
2023-08-12 |
Not clear |
| Sally I Sharp, Clive G Ballard, Iryna Ziabreva, Margaret A Piggott, Robert H Perry, Elaine K Perry, Dag Aarsland, Uwe Ehrt, Jan P Larsen, Paul T Franci. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders. vol 26. issue 4. 2009-02-09. PMID:18841018. |
serotonin 1a receptors (5-ht(1a)) have not been studied in dementia with lewy bodies (dlb) or parkinson's disease dementia (pdd) patients with depression. |
2009-02-09 |
2023-08-12 |
Not clear |
| Jennifer M Hughes, Oliver Wirth, Kristine Krajnak, Roger Miller, Sheila Flavahan, Dan E Berkowitz, Dan Welcome, Nicholas A Flavaha. Increased oxidant activity mediates vascular dysfunction in vibration injury. The Journal of pharmacology and experimental therapeutics. vol 328. issue 1. 2009-02-03. PMID:18955588. |
inhibition of nitric-oxide synthase (nos) with n(omega)-nitro-l-arginine methyl ester (l-name) increased constriction to phenylephrine or 5-hydroxytryptamine in vibrated but not control arteries and abolished the vibration-induced depression in constrictor responses. |
2009-02-03 |
2023-08-12 |
rat |
| Jennifer M Hughes, Oliver Wirth, Kristine Krajnak, Roger Miller, Sheila Flavahan, Dan E Berkowitz, Dan Welcome, Nicholas A Flavaha. Increased oxidant activity mediates vascular dysfunction in vibration injury. The Journal of pharmacology and experimental therapeutics. vol 328. issue 1. 2009-02-03. PMID:18955588. |
catalase also increased constriction to phenylephrine or 5-hydroxytryptamine in vibrated but not control arteries and abolished the vibration-induced depression in constrictor responses. |
2009-02-03 |
2023-08-12 |
rat |
| Heng-qiang Gao, Hai-yan Zhu, Yan-qiang Zhang, Le-xin Wan. Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report. Clinical and investigative medicine. Medecine clinique et experimentale. vol 31. issue 6. 2009-02-02. PMID:19032905. |
reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: a preliminary report. |
2009-02-02 |
2023-08-12 |
Not clear |
| Heng-qiang Gao, Hai-yan Zhu, Yan-qiang Zhang, Le-xin Wan. Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report. Clinical and investigative medicine. Medecine clinique et experimentale. vol 31. issue 6. 2009-02-02. PMID:19032905. |
to investigate the plasma and cerebrospinal fluid (csf) concentrations of serotonin in patients with post-stroke depression (psd). |
2009-02-02 |
2023-08-12 |
Not clear |
| Philip J Cowe. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends in pharmacological sciences. vol 29. issue 9. 2009-01-30. PMID:18585794. |
serotonin and depression: pathophysiological mechanism or marketing myth? |
2009-01-30 |
2023-08-12 |
Not clear |
| Philip J Cowe. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends in pharmacological sciences. vol 29. issue 9. 2009-01-30. PMID:18585794. |
the notion that impaired serotonin (5-ht) function can lead to clinical depression has a long history but is still controversial. |
2009-01-30 |
2023-08-12 |
Not clear |
| Philip J Cowe. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends in pharmacological sciences. vol 29. issue 9. 2009-01-30. PMID:18585794. |
some have argued that the 5-ht hypothesis has been misused by the pharmaceutical industry to promote a simplistic biological model of depression to market selective serotonin reuptake inhibitors (ssris) to medical practitioners and the public. |
2009-01-30 |
2023-08-12 |
Not clear |
| Philip J Cowe. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends in pharmacological sciences. vol 29. issue 9. 2009-01-30. PMID:18585794. |
the best evidence that 5-ht contributes to the pathophysiology of depression comes from studies of tryptophan depletion, which show that lowering brain 5-ht levels can induce acute symptomatic relapse in recovered depressed patients. |
2009-01-30 |
2023-08-12 |
Not clear |
| Philip J Cowe. Serotonin and depression: pathophysiological mechanism or marketing myth? Trends in pharmacological sciences. vol 29. issue 9. 2009-01-30. PMID:18585794. |
clarification of the mechanism of this effect will enable an understanding of how impaired 5-ht activity contributes to the subjective experience of depression. |
2009-01-30 |
2023-08-12 |
Not clear |
| Yang Luo, Le-zhi Zheng, Jian-wei Zhou, Pi-xiang P. [Relationship between the levels of estradiol and monoamine neurotransmitters and postpartum depression]. Zhonghua fu chan ke za zhi. vol 42. issue 11. 2009-01-26. PMID:18307900. |
to explore the relationship of estradiol (e(2)), monoamine neurotransmitters 5-hydroxytryptamine (5-ht), dopamine (da) and postpartum depression. |
2009-01-26 |
2023-08-12 |
Not clear |
| Mostafa El Mansari, Ramez Ghanbari, Shannon Janssen, Pierre Blie. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology. vol 55. issue 7. 2009-01-26. PMID:18708076. |
the gradual recovery of neuronal firing of ne neurons, due to the desensitization of alpha2-adrenoceptors, in the presence of the sustained increase in 5-ht neuronal firing, may explain in part the delayed onset of action of bupropion in major depression. |
2009-01-26 |
2023-08-12 |
rat |
| Jaques Beli. Fetal and neonatal effects of maternal drug treatment for depression. Seminars in perinatology. vol 32. issue 5. 2009-01-26. PMID:18929158. |
depression has a female sex predilection with 2 to 3% of the pregnant women population presently requiring treatment with selective serotonin reuptake inhibitors (ssri). |
2009-01-26 |
2023-08-12 |
rat |
| Lynn G Kirby, Emily Freeman-Daniels, Julia C Lemos, John D Nunan, Christophe Lamy, Adaure Akanwa, Sheryl G Bec. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 28. issue 48. 2009-01-26. PMID:19036986. |
stress-related psychiatric disorders such as anxiety and depression involve dysfunction of the serotonin [5-hydroxytryptamine (5-ht)] system. |
2009-01-26 |
2023-08-12 |
rat |
| S G Hasselbalch, K Madsen, C Svarer, L H Pinborg, S Holm, O B Paulson, G Waldemar, G M Knudse. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment. Neurobiology of aging. vol 29. issue 12. 2009-01-23. PMID:17544547. |
reduced 5-ht(2a) binding in the striatum correlated significantly with neuropsychiatric inventory depression and anxiety scores. |
2009-01-23 |
2023-08-12 |
human |
| Zdenek Fisar, Lucie Kalisová, Ivo Paclt, Martin Anders, Jan Vever. Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram. Psychiatry research. vol 161. issue 2. 2009-01-23. PMID:18817980. |
we investigated the kinetic parameters of serotonin (5-ht) uptake into platelets in a group of 26 drug-naïve patients suffering from major depression before and after 3-7 weeks of treatment with citalopram. |
2009-01-23 |
2023-08-12 |
human |